ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance
ALKTERNATE:一项在既往ALK抑制剂耐药的ALK阳性非小细胞肺癌患者中交替使用洛拉替尼和克唑替尼的试点研究。
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100703
Itchins, Malinda; Liang, Shirley; Brown, Chris; Barnes, Tristan; Marx, Gavin; Chin, Venessa; Kao, Steven; Yip, Po Yee; Mersiades, Antony J; Nagrial, Adnan; Bray, Victoria; Peters, Geoffrey; Parakh, Sagun; Garg, Kavita; Li, Bob T; McKay, Matthew; O'Byrne, Kenneth; John, Thomas; Gill, Anthony J; Molloy, Mark P; Solomon, Benjamin J; Pavlakis, Nick